Literature DB >> 16500328

Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.

Guido Ragni1, Ilaria Caliari, Anna Elisa Nicolosi, Mariangela Arnoldi, Edgardo Somigliana, Pier Giorgio Crosignani.   

Abstract

OBJECTIVE: To employ protocols of mild ovarian stimulation to prevent an excessively elevated rate of high-order multiple pregnancies.
DESIGN: Case series.
SETTING: University hospital. PATIENT(S): Six hundred and twenty one consecutive patients undergoing 1,259 controlled ovarian hyperstimulation and intrauterine insemination cycles. INTERVENTION(S): Patients received 50 IU per day of recombinant follicle-stimulating hormone (FSH) starting the third day of the cycle, then a gonadotropin-releasing hormone (GnRH) antagonist on the day in which a follicle > or =13 mm was visualized. Cycles were canceled if three or more follicles > or =16 mm and/or five or more follicles > or =11 mm were detected. MAIN OUTCOME MEASURE(S): Rate of high-order multiple pregnancies. RESULT(S): The clinical pregnancy rate per initiated cycle was 9.2% (95% confidence interval, 7.5-11.1%). The incidence of twins and high-order multiple pregnancies was 9.5% (95% CI, 5.3-16.2%) and 0 (0.0-3.2%), respectively. CONCLUSION(S): In controlled ovarian hyperstimulation and intrauterine insemination cycles, a protocol of 50 IU of recombinant FSH daily combined with the use of GnRH antagonists and a policy of strict cancellation based on echographic criteria are associated with a satisfactory pregnancy rate per initiated cycle and a low risk of high-order multiple pregnancies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500328     DOI: 10.1016/j.fertnstert.2005.09.021

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.

Authors:  Ramazan Dansuk; Ali Ihsan Gonenc; Sinem Sudolmus; Oguz Yucel; Osman Sevket; Nadiye Köroğlu
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

2.  Aspiration of excess follicles before intrauterine insemination in high response cycles.

Authors:  Begoña Prieto; Maria Diaz-Nuñez; Lucia Lainz; Alberto Vendrell; Aintzane Rabanal; Maria Iglesias; Teresa Jauregui; Beatriz Corcostegui; Ana Matorras; Silvia Perez; Roberto Matorras
Journal:  Reprod Med Biol       Date:  2022-06-29

3.  Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination.

Authors:  Robert Streda; Tonko Mardesic; Vladimir Sobotka; Dana Koryntova; Lucie Hybnerova; Martin Jindra
Journal:  Arch Gynecol Obstet       Date:  2012-06-27       Impact factor: 2.344

4.  Intra-uterine insemination for unexplained subfertility.

Authors:  Reuben Olugbenga Ayeleke; Joyce Danielle Asseler; Ben J Cohlen; Susanne M Veltman-Verhulst
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

5.  Minimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine insemination.

Authors:  Bo Hyon Yun; Seung Joo Chon; Joo Hyun Park; Seok Kyo Seo; SiHyun Cho; Young Sik Choi; Seok Hyun Kim; Byung Seok Lee
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.